Holen Sie sich die Stockscreener-App
6.60
3.23%
-0.22
Silexion Therapeutics Corp Aktie (SLXN) Neueste Nachrichten
Is There Enough Volume to Lift Silexion Therapeutics Corp Equity WarrantWeekly Market Report & AI Based Buy/Sell Signal Reports - beatles.ru
Silexion Therapeutics Executes Reverse Stock Split - TipRanks
Silexion Therapeutics Increases Authorized Share Capital - MSN
Silexion Therapeutics shareholders approve increase in authorized share capital By Investing.com - Investing.com Canada
Silexion Therapeutics Corp Reversal Rally May Surprise BearsJuly 2025 PreEarnings & AI Based Trade Execution Alerts - thegnnews.com
Silexion Therapeutics shareholders approve increase in authorized share capital - Investing.com
Is This a Bottoming Phase for Silexion Therapeutics CorpJuly 2025 Highlights & Community Verified Swing Trade Signals - newsimpact.co.kr
Is Silexion Therapeutics Corp Equity Warrant stock reversal real or fakeJuly 2025 Reactions & Real-Time Stock Movement Alerts - Newser
Advanced analytics toolkit walkthrough for Silexion Therapeutics Corp2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - Newser
Should you hold or exit Silexion Therapeutics Corp Equity Warrant nowEarnings Trend Report & High Conviction Investment Ideas - Newser
What to do if you’re stuck in Silexion Therapeutics CorpFed Meeting & Low Drawdown Trading Strategies - Newser
What high frequency data says about Silexion Therapeutics CorpJuly 2025 Short Interest & Weekly Breakout Watchlists - Newser
Silexion Therapeutics Corp Equity Warrant stock trendline breakdown2025 EndofYear Setup & Risk Adjusted Swing Trade Ideas - Newser
Using flow based indicators on Silexion Therapeutics Corp Equity WarrantWeekly Stock Analysis & Safe Capital Investment Plans - Newser
Is Silexion Therapeutics Corp still worth holding after the dipQuarterly Trade Summary & Real-Time Sentiment Analysis - Newser
Silexion Therapeutics Corp Company’s Quarterly Earnings Growth: What the Numbers SayGap Down & Weekly Top Performers Watchlists - Newser
Published on: 2025-08-17 04:35:28 - Newser
Will Silexion Therapeutics Corp bounce back from current supportPortfolio Update Summary & Safe Capital Investment Plans - Newser
Is Silexion Therapeutics Corp Equity Warrant in Accumulation Phase Now2025 Technical Patterns & Daily Profit Maximizing Tips - newsyoung.net
Does Silexion Therapeutics Corp qualify in momentum factor screeningJuly 2025 Selloffs & Technical Entry and Exit Alerts - Newser
Is Silexion Therapeutics Corp Equity Warrant stock good for income investorsJuly 2025 Review & Daily Oversold Stock Bounce Ideas - thegnnews.com
Is Silexion Therapeutics Corp stock ready for a breakoutMarket Risk Analysis & Fast Moving Trade Plans - Newser
Chart overlay techniques for tracking Silexion Therapeutics Corp2025 Price Targets & Reliable Breakout Stock Forecasts - Newser
How to interpret RSI for Silexion Therapeutics Corp Equity Warrant stockDay Trade & AI Enhanced Execution Alerts - Newser
Exit strategy if you’re trapped in Silexion Therapeutics CorpTrade Risk Summary & Short-Term High Return Ideas - Newser
Risk adjusted return profile for Silexion Therapeutics Corp analyzedWeekly Stock Analysis & AI Driven Stock Movement Reports - Newser
What is Silexion Therapeutics Corp’s market positionWeekly Stock Analysis & Entry Point Confirmation Alerts - 선데이타임즈
Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - ADVFN Brasil
Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - ADVFN Brasil
Order Book Volume Tilts Bullish on Silexion Therapeutics Corp2025 AllTime Highs & High Yield Equity Trading Tips - newsimpact.co.kr
How sensitive is Silexion Therapeutics Corp Equity Warrant to inflationEarnings Miss & Weekly Chart Analysis and Trade Guides - sundaytimes.kr
How Silexion Therapeutics Corp stock performs during market volatilityMarket Weekly Review & Fast Moving Market Watchlists - Newser
Form 424B3 Silexion Therapeutics - StreetInsider
Silexion Therapeutics reports Q2 EPS ($4.32) vs. ($197.80) last year - TipRanks
Breakthrough: Silexion's Cancer Drug Shows 97% Efficacy Across Multiple Tumor Types, Phase 2/3 Trials Coming - Stock Titan
What are Silexion Therapeutics Corp company’s key revenue driversInvest confidently with professional guidance - Jammu Links News
What is Silexion Therapeutics Corp company’s growth strategyGet insider insights into market trends - Jammu Links News
What is the dividend policy of Silexion Therapeutics Corp Equity Warrant stockBuild wealth faster with consistent investment plans - Jammu Links News
How strong is Silexion Therapeutics Corp Equity Warrant company’s balance sheetMaximize portfolio value with expert tips - Jammu Links News
What are Silexion Therapeutics Corp Equity Warrant company’s key revenue driversAchieve breakthrough investment performance - Jammu Links News
How does Silexion Therapeutics Corp generate profit in a changing economyMaximize returns with strategic trading plans - Jammu Links News
How does Silexion Therapeutics Corp Equity Warrant compare to its industry peersRobust investment performance - Jammu Links News
Is Silexion Therapeutics Corp a growth stock or a value stockOutstanding risk-reward balance - Jammu Links News
Should I hold or sell Silexion Therapeutics Corp stock in 2025Free Daily Trading Room Entry - Jammu Links News
What makes Silexion Therapeutics Corp stock price move sharplyAchieve rapid growth with smart investments - Jammu Links News
What are the latest earnings results for Silexion Therapeutics CorpMaster the art of timing market moves - Jammu Links News
Is Silexion Therapeutics Corp Equity Warrant stock overvalued or undervaluedDouble-digit growth - Jammu Links News
Silexion Therapeutics Corp Stock Analysis and ForecastMarket-crushing stock picks - Jammu Links News
What is Silexion Therapeutics Corp Equity Warrant company’s growth strategyExponential wealth increase - Jammu Links News
When is Silexion Therapeutics Corp Equity Warrant stock expected to show significant growthUnlock powerful insights from market experts - Jammu Links News
Should I hold or sell Silexion Therapeutics Corp Equity Warrant stock in 2025Unlock powerful trading techniques - Jammu Links News
Is Silexion Therapeutics Corp Equity Warrant a good long term investmentUnlock powerful trading signals and alerts - Jammu Links News
When is Silexion Therapeutics Corp stock expected to show significant growthUnlock powerful stock screening tools today - Jammu Links News
What makes Silexion Therapeutics Corp Equity Warrant stock price move sharplyHigh-performance stocks for savvy investors - Jammu Links News
What catalysts could drive Silexion Therapeutics Corp Equity Warrant stock higher in 2025Exceptional profit potential - Jammu Links News
Why is Silexion Therapeutics Corp stock attracting strong analyst attentionBuild wealth faster with disciplined trading - Jammu Links News
How volatile is Silexion Therapeutics Corp Equity Warrant stock compared to the marketUnlock powerful insights from market experts - Jammu Links News
What catalysts could drive Silexion Therapeutics Corp stock higher in 2025Access exclusive market insights for free - Jammu Links News
How strong is Silexion Therapeutics Corp company’s balance sheetStrongest growth potential - Jammu Links News
Buy Rating for Silexion Therapeutics Driven by Promising Preclinical Data and Financial Strength - TipRanks
Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds - GlobeNewswire
Silexion Therapeutics Enters Inducement Offer Agreement - TipRanks
[8-K] Silexion Therapeutics Corp Reports Material Event | SLXN SEC FilingForm 8-K - Stock Titan
Silexion Therapeutics stock falls after warrant exercise deal By Investing.com - Investing.com Australia
Silexion Therapeutics stock falls after warrant exercise deal - Investing.com India
0.95%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):